YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)
Sponsors
Bayer
Conditions
Acne VulgarisContraceptionContraceptives, Oral
Phase 2
Phase 3
Efficacy and Safety Oral Contraceptive Study
CompletedNCT00185484
Start: 2004-03-31End: 2006-01-31Updated: 2014-12-31
Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.
CompletedNCT00651469
Start: 2003-01-31End: 2004-07-31Updated: 2014-12-30
Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne
CompletedNCT00656981
Start: 2003-01-31End: 2004-06-30Updated: 2014-12-30